Top Markets
Coin of the day
Regent Pacific Group Limited Regent Pacific Group Limited

Regent Pacific Group Limited

0575
Rang in Aktien #27223
Endurance RP Limited functions as an investment holding company, concentrating... Endurance RP Limited functions as an investment holding company, concentrating its investments within the healthcare and life sciences sectors across the People's Republic of China, Europe, Hong Kong, and Taiwan. The firm organizes its activities into two primary divisions: Biopharma and Corporate Investment. The Biopharma segment is responsible for the research, development, production, promotion, and distribution of pharmaceutical products aimed at addressing and managing urological disorders. This division also innovates artificial intelligence systems to precisely track the pace of aging, examining it at molecular, cellular, tissue, organ, systemic, physiological, and psychological levels. Through its Corporate Investment division, the company strategically invests in both publicly traded and privately held corporate entities. Additionally, it extends its services to include management consulting and corporate financial advice. Incorporated in 1991 and headquartered in Central, Hong Kong, Endurance RP Limited adopted its current name in June 2021, having previously operated as Regent Pacific Group Limited.
Aktienkurs
$0.11769213
Zuletzt synchronisiert: 2026-07-30
Marktkapitalisierung
$34.34M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
9.45%
Land
HK
Handel Regent Pacific Group Limited (0575)

Kategorie

P/B-Verhältnis für Regent Pacific Group Limited (0575)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Regent Pacific Group Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Regent Pacific Group Limited von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.1618 -
US
12.5083 -
US
- -
SE
3.2887 -
US
1.8735 -
US